A strategy update with IDL Diagnostics was held on November 27th at Redeye, where CEO Anders Hultman and the management team presented recent achievements, spotlighted key initiatives, and discussed future opportunities looking toward 2026 and beyond. After their presentation, Redeye analyst Oscar Bergman moderated a Q&A session.
IDL Diagnostics at Urology Week in Växjö
Last week, IDL Diagnostics participated in Urology Week 2026 in Växjö. The event brought together professionals from across the field of urology and offered a valuable opportunity to engage in discussions about current research, clinical perspectives and ongoing...
